YH-02
AXP000062.1 · Oncolytic virus
- Platform
- adenovirus
- Sponsor
- Tianjin First Central Hospital
Names
| Name | Type | Source |
|---|---|---|
| YH-02 ambiguous | preferred name, code | curator, ctgov |
Virus
- Role
- Oncolytic
- Family
- Adenoviridae
- Virus
- human adenovirus (serotype not reported)
- Replication
- conditionally replicating
- Source
- evidence
Approvals
No regulatory approval recorded.
Clinical trials (1)
| Trial | Title | Status | Phase | Start | Primary completion | Enrolment | Conditions |
|---|---|---|---|---|---|---|---|
| NCT07697937 | YH02 Injection for Intra-tumor Injection Therapy in Advanced Solid Tumors With Unresponsive or Failure-Treated Cases | Recruiting | Phase 2 | 2026-06-23 | 2028-05-31 | 50 | Advanced Malignant Solid Tumor |
Recent changes
No changes recorded in its trials yet.
Clinical papers
No confirmed clinical papers yet.
Other papers
Preclinical studies, reviews and other papers that name it.
No confirmed other papers yet.
Unconfirmed matches (2)
Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 40635172 | Chemical Constituents of Rabdosia Species and Their Antimicrobial and Antioxidant Activities in Extending Meat Shelf Life. | Journal of food science | 2025 | name in abstract: YH-02 |
| PMID 24812969 | [Risk assessment and countermeasures of heavy metals pollution in Wanquan segment of Yanghe River]. | Huan jing ke xue= Huanjing kexue | 2014 | name in abstract: YH-02 |
Notes
Oncolytic adenovirus in trial NCT07697937. Construct not described; classification as an adenovirus rests on the trial's indexing and should be re-checked.
How to cite
YH-02 (AXP000062.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000062.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.